, increase the 2 hemodialysis centers in 2018, and the number of dialysis patients has increase as continuously to fully. As a result, the revenue in this segment has grown as significant when compared with
capacity utilization following a steady contraction in export value. Meanwhile, public investment expanded as a result of an acceleration in disbursements by the government. Headline inflation in the second
value to its shareholders. 2Q 2018 Highlights Core EBITDA increased 63% year-on-year to $388 million, driven by strong demand growth led by Asia supporting enhanced margins in the Polyester value chain
cloud revenue in 1Q23. • Regulatory fee was Bt1,394mn, increased 2.7% YoY aligned with core service revenue growth while staying flat QoQ. The regulatory fee as % of core service revenue was at 4.2
2Q20. As a result, regulatory fee to core service revenue was 4.2% in 3Q20, comparing to 4.0% in 2Q20. Depreciation & amortization increased from continued network investment and new spectrum. D&A was
, AIS reported a core service revenue of Bt35,394mn for 2Q19, growing 5.8% YoY and 4.2% QoQ. In this quarter, there was a one- time expense1 on legal severance compensation amounting to Bt636mn. Excluding
the Thai economy driven by the relaxation of controls and lower concerns on COVID-19 situation which brought in foreign tourists and increased business activities. Overall, AIS reported core service
profit was Bt104.3mn, decreasing 28.2% YoY • Total revenue from core business was Bt667mn, decreasing 17.1% • Banking agent business (of which the Company is the agent for 6 commercial banks: KTB, KANK
-3%QoQ. As a result, EBITDA (Pre-TFRS16) in 4Q20 declined -1.7%YoY from weak core service revenue, but increased 1%QoQ from cost control in SG&A. Net profit (Pre-TFRS 16) increased 5%YoY and 9.7%QoQ
chronic kidney disease. Present, patient who replacement therapy with dialysis with dialysis machines was increased steadily to fully capacity. And July 16, 2018, has opened and operated new hemodialysis